Categories

August 2022

General Corporate Affairs

Explanations for the Chairman’s Inability to Exercise Authority (Taiwan)

理慈

August 2022

Competition Law

The Fair Trade Commission of Taiwan Penalized a Gaming Operator's Act of False Probability Claims of Opportunistic Goods

理慈

August 2022

General Corporate Affairs

Post-Epidemic Era – Bottlenecks and Reflections on Taiwan's E-chop System

理慈

August 2022

Fintech

The Financial Supervisory Commission of Taiwan Will Begin to Accept the Application for the Establishment of Neo Insurers in August 2022

理慈

August 2022

LTP Special Column

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (VI) –The MOEA of Taiwan Pre-announced Draft Sub-law: Regulations Governing Management of Research Personnel’s Concurrent Holding of Jobs and Investments by Contribution of Technology to Start-up Biotech and Pharmaceutical Company

理慈

August 2022

LTP Special Column

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (V) –The Draft Regulations Announced by the MOEA and MOF of Taiwan: Regulations Governing the Tax Deferral for a Top Executive or Technology Investor in Biotech and Pharmaceutical Companies, Regulations Governing Biotech and Pharmaceutical Companies' Issuance of Stock Options, and Regulations Governing Application of Deferred Taxation of Income Tax in Accordance with the Act for the Development of Biotech and Pharmaceutical Industry

理慈